Skip to main content
. Author manuscript; available in PMC: 2013 Jul 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2013 Feb 21;71(5):1183–1190. doi: 10.1007/s00280-013-2112-2

Table 3.

Summary of toxicities

Toxicity, N (%) Worst grade N = 11
1/2 3 4 5
Leukopenia 6 (55) 2 (18) 1 (9)
Neutropenia 3 (27) 1 (9)
Lymphopenia 1 (9) 2 (18) 8 (73)
CD4 counta 1 (14) 6 (86)
Hemoglobin 3 (27) 2 (18) 1 (9)
Platelets 6 (55) 1 (9)
Infection 1 (9) 3 (27)
Hypersensitivity 2 (18)
Rash 4 (36)
Diarrhea 4 (36) 1 (9)
Nausea 4 (36) 1 (9)
Vomiting 2 (18)
Mucositis 2 (18) 1(9)
Constitutional 2 (18) 5 (45)
Metabolic 5 (45) 1 (9)
Pulmonary 2 (18) 2 (18)

1 patient had DLT on dose level 2 (fatigue, dyspnea–grade 3)

a

Percentages for CD4 Count use a denominator of 7, the number of patients evaluated for CD4 toxicity